ATE311447T1 - Herstellung von rekombinantem faktor viii in gegenwart von liposom-ähnliche verbindung- zusammensetzungen - Google Patents

Herstellung von rekombinantem faktor viii in gegenwart von liposom-ähnliche verbindung- zusammensetzungen

Info

Publication number
ATE311447T1
ATE311447T1 AT96106482T AT96106482T ATE311447T1 AT E311447 T1 ATE311447 T1 AT E311447T1 AT 96106482 T AT96106482 T AT 96106482T AT 96106482 T AT96106482 T AT 96106482T AT E311447 T1 ATE311447 T1 AT E311447T1
Authority
AT
Austria
Prior art keywords
liposome
factor viii
recombinant factor
preparation
compound compositions
Prior art date
Application number
AT96106482T
Other languages
English (en)
Inventor
Sham-Yuen Chan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/434,900 external-priority patent/US5679549A/en
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE311447T1 publication Critical patent/ATE311447T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT96106482T 1995-05-04 1996-04-25 Herstellung von rekombinantem faktor viii in gegenwart von liposom-ähnliche verbindung- zusammensetzungen ATE311447T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/434,900 US5679549A (en) 1995-05-04 1995-05-04 Production of recombinant factor VIII in the presence of liposome-like substances of mixed composition
US08/634,001 US5952198A (en) 1995-05-04 1996-04-17 Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition

Publications (1)

Publication Number Publication Date
ATE311447T1 true ATE311447T1 (de) 2005-12-15

Family

ID=27030345

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96106482T ATE311447T1 (de) 1995-05-04 1996-04-25 Herstellung von rekombinantem faktor viii in gegenwart von liposom-ähnliche verbindung- zusammensetzungen

Country Status (7)

Country Link
US (1) US5952198A (de)
EP (1) EP0745672B1 (de)
JP (1) JP3996655B2 (de)
AT (1) ATE311447T1 (de)
AU (1) AU710853B2 (de)
CA (1) CA2175628C (de)
DE (1) DE69635504T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200560B1 (en) * 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6358703B1 (en) * 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
US7625584B2 (en) * 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US8110218B2 (en) * 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
AU2002248190A1 (en) * 2000-11-30 2002-08-12 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US20020132982A1 (en) * 2000-11-30 2002-09-19 Balasubramanian Sathyamangalam V. AHF associated dispersion system and method for preparation
US20050221414A1 (en) 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
EP1988101A1 (de) 2007-05-04 2008-11-05 Novo Nordisk A/S Verbesserung von Faktor-VIII-Polypeptid-Titern in Zellkulturen
US20150045303A1 (en) * 2012-04-24 2015-02-12 Novo Nordisk A/S Pharmaceutical Composition Suitable for Treatment of Haemophilia
JP2017500893A (ja) 2013-12-20 2017-01-12 エッセンシャル ファーマシューティカル エルエルシー 細胞培養のための培地
CN108884145B (zh) * 2015-11-13 2023-08-22 武田药品工业株式会社 用于血友病a的基因治疗的具有增加的表达的编码重组fviii变体的病毒载体
JP2018023356A (ja) * 2016-08-04 2018-02-15 三洋化成工業株式会社 有用物質の生産方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE87663T1 (de) * 1986-01-03 1993-04-15 Genetics Inst Verfahren zur herstellung von faktor-viii:c-typ- proteinen.
US5250421A (en) * 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
DE3769872D1 (de) * 1986-07-11 1991-06-13 Miles Inc Herstellung von rekombinantem protein.

Also Published As

Publication number Publication date
AU710853B2 (en) 1999-09-30
EP0745672A3 (de) 1998-05-20
DE69635504T2 (de) 2006-06-14
JPH0998796A (ja) 1997-04-15
AU5207196A (en) 1996-11-28
EP0745672A2 (de) 1996-12-04
JP3996655B2 (ja) 2007-10-24
CA2175628A1 (en) 1996-11-05
EP0745672B1 (de) 2005-11-30
US5952198A (en) 1999-09-14
CA2175628C (en) 2007-02-20
DE69635504D1 (de) 2006-01-05

Similar Documents

Publication Publication Date Title
DE69635504T2 (de) Herstellung von rekombinantem Faktor VIII in Gegenwart von Liposom-ähnliche Verbindung-Zusammensetzungen
BR9510080A (pt) Lipopoliamina sob forma D,L, ou DL ou um de seus sais e composição farmacêutica
AU5914186A (en) Method and composition for making lipsomes
AU1724097A (en) Lipids and their use, for example, in liposomes
GR1000247B (el) Σταθεραι λυοφιλιωμεναι διαμορφωσεις περιεχουσαι παραγοντας αναπτυξεως.
BR9607999A (pt) Composiçao e processo de preparaçao de uma composiçao de proteína lipossômica
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
CA2097199A1 (en) Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids
CA2270396A1 (en) Cationic reagents for transfection
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
EP1046347A4 (de) Gelierte nahrungsmittel sowie verfahren zu deren herstellung
EP0675136A3 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung.
NO20013862L (no) Fremgangsmåte for å regulere liposomstörrelse
CA2079685A1 (en) Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
TR200000175T2 (tr) Endogenik gen aktivasyonu ile eritropoietinin hazırlanması.
DE3879803D1 (de) Reinigung von faktor viii:c durch phospholipid-affinitaet.
CH692199A8 (fr) Composes pyridiques et compositions pharmaceutique
AU588994B2 (en) Novel benzodiazepine derivatives and their preparation and use
EP0478715A4 (en) Targeted liposomes and methods for liposome-protein coupling
CA2117769A1 (en) Liposome composition
IL75315A0 (en) Vesicle stabilization
GR3019592T3 (en) Drug formulations by liposomes and the process for their manufacture
AU9532198A (en) Ribonucleoside-derivative and method for preparing the same
RU94038254A (ru) Циклические аминопроизводные, способ их получения, фармацевтические композиции и способ их получения
AU6922891A (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties